Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell tags : Car-t save search
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 2.33%
H: 2.28%
C: -4.23%
hope treatment pharmaceuticals city for car-t trial
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: 1.63%
H: 0.54%
C: -0.67%
cb-012 association cancer cell research preclinical meeting car-t
France CAR-T Cell Therapy Market 2018-2028F - Expansion of Indications Beyond Hematological Malignancies
Published: 2024-02-09 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
MO 4 | $42.09 1.91% -0.42% 22M
|
Consumer Non-Durables
|
| O: -0.35%
H: 0.5%
C: 0.4%
beyond cell expansion car-t therapy market
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.16%
H: 0.17%
C: -1.16%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 2.85%
H: 0.0%
C: -7.69%
pipeline cell collaboration car-t therapy
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
Published: 2024-01-04 (Crawled : 00:00) - biospace.com/
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
abbvie cell biopharma collaboration car-t
Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted CAR-T Cell Therapy Candidate NXC-201 for Relapsed/Refractory AL AmyloidosisVirtual Event to be held on November 29, 2023 at 4:15 p.m. ET
Published: 2023-11-22 (Crawled : 17:00) - biospace.com/
IMMX | News | $2.21 0.0% 64K
|
|
| O: 1.91%
H: 3.85%
C: 3.04%
nxc-201 candidate cell biopharma car-t therapy
Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted CAR-T Cell Therapy Candidate NXC-201 for Relapsed/Refractory AL Amyloidosis
Published: 2023-11-22 (Crawled : 14:00) - globenewswire.com
IMMX | News | $2.21 0.0% 64K
|
|
| O: 1.91%
H: 3.85%
C: 3.04%
nxc-201 candidate cell biopharma car-t therapy
Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
ARE A | $115.69 -0.7% 0.0% 940K
|
Finance
|
| O: -0.31%
H: 0.32%
C: -0.74%
GLPG | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 4.99%
H: 0.15%
C: -2.11%
multi-year cell car-t agreement therapy
Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma
Published: 2023-10-26 (Crawled : 13:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 10.19%
H: 21.97%
C: -18.5%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.53%
H: 2.93%
C: -4.26%
mb-109 fda mb-101 cell treatment application car-t glioblastoma
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program
Published: 2023-10-25 (Crawled : 13:30) - prnewswire.com
RGBP | $0.7 5.69% 11K
|
Manufacturing
|
| O: 4.29%
H: 10.0%
C: 10.0%
cell car-t program therapy
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 15:30) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.24%
H: 7.12%
C: 4.11%
bnt211 candidate congress tumors positive update cell car-t therapy
Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: -5.35%
cb-012 fda cell treatment clearance application car-t leukemia therapy
Actinium Announces NIH Grant Extension to Advance Clinical Development of Next-Generation CD45 Targeted Conditioning Agent Iomab-ACT with Memorial Sloan Kettering's CAR-T Cell Therapy
Published: 2023-10-04 (Crawled : 13:00) - biospace.com/
ATNM | $6.85 2.7% 0.0% 350K
|
Health Technology
|
| O: 0.87%
H: 2.41%
C: -0.69%
cd45 cell extension grant car-t therapy
Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership Program to Evaluate Automated Manufacturing of CAR-T Cell Therapy on the Cell Shuttle Platform
Published: 2023-08-28 (Crawled : 14:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.03%
H: 0.56%
C: -0.68%
partnership cell car-t program technology therapy platform
Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies
Published: 2023-08-17 (Crawled : 15:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: -1.54%
H: 4.53%
C: -1.56%
institute cell research car-t technology therapeutics
Mustang Bio Announces First Data from Ongoing Multicenter Phase 1/2 Clinical Trial Evaluating MB-106 CAR-T Cell Therapy
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 5.53%
H: 0.0%
C: -9.23%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 1372.45%
H: 1.87%
C: -3.85%
mb-106 cell ongoing car-t trial therapy
Marker Therapeutics to Participate in Virtual Roundtable with Key Opinion Leaders to Discuss Clinical Landscape of CAR-T Cell Therapies on August 9, 2023
Published: 2023-07-26 (Crawled : 11:00) - globenewswire.com
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: 1.14%
H: 9.01%
C: -3.94%
cell car-t therapeutics
Global CAR-T Cell Therapy Market Report 2023: Rise in Awareness Regarding CAR T-Cell Therapy Drives Growth
Published: 2023-07-06 (Crawled : 19:00) - prnewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: 0.32%
H: 25.69%
C: 21.83%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.7%
H: 0.36%
C: -0.76%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.5%
H: 0.14%
C: -1.45%
report t-cell cell global car-t therapy growth market
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-CD19CD20-ALLO1, an Allogeneic Dual CAR-T Cell Therapy for B-Cell Malignancies
Published: 2023-07-05 (Crawled : 13:00) - biospace.com/
PSTX | News | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 8.67%
H: 13.2%
C: -9.57%
cd19 fda drug cell clearance application car-t therapeutics therapy
Panbela Announces Sponsored Research Agreement to Evaluate Polyamine Metabolic Inhibitor Therapy in Combination with CAR-T Cell Therapy
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
PBLA | $0.4895 -6.31% 66K
|
Professional, Scientific, and T...
|
| O: 13.23%
H: 22.83%
C: -16.44%
metabolic cell research car-t agreement therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.